Post-approval studies (Phase 4)Study completedNCT05007041What this trial is testingSimultaneous RZV and aIIV4 VaccinationWho this might be right forPainQuality of LifeInjection Site Reaction+1 more Duke University 267
Large-scale testing (Phase 3)Study completedNCT02612909What this trial is testingA Safety and Immunogenicity Study of IVACFLU-A/H5N1Who this might be right forAvian Influenza Institute of Vaccines and Medical Biologicals, Vietnam 930
Large-scale testing (Phase 3)Study completedNCT02710409What this trial is testingA Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and OlderWho this might be right forInfluenza Jiangsu Province Centers for Disease Control and Prevention 3,664
Large-scale testing (Phase 3)Study completedNCT02344134What this trial is testingStudy of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly SubjectsWho this might be right forInfluenza, Human SK Chemicals Co., Ltd. 1,155
Large-scale testing (Phase 3)Study completedNCT00231816What this trial is testingAn Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)Who this might be right forHerpes Zoster Merck Sharp & Dohme LLC 763
Not applicableStudy completedNCT02006784What this trial is testingPilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus (SLE) Vanderbilt University 17
Testing effectiveness (Phase 2)Study completedNCT05297994What this trial is testingTrial of the Reactogenicity, Safety and Immunogenicity of the Flu-M Vaccine Manufactured by FSUE SPbSRIVS FMBAWho this might be right forInfluenza St. Petersburg Research Institute of Vaccines and Sera 400
Large-scale testing (Phase 3)Study completedNCT00521586What this trial is testingStudy Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza VaccineWho this might be right forInfluenza Pfizer 1,116
Large-scale testing (Phase 3)Study completedNCT00192205What this trial is testingTrial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in ChildrenWho this might be right forRespiratory Tract Infections MedImmune LLC 2,200
Large-scale testing (Phase 3)Study completedNCT05144945What this trial is testingStudy Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South KoreaWho this might be right forInfluenza (Healthy Volunteers) Sanofi Pasteur, a Sanofi Company 301
Not applicableStudy completedNCT03057483What this trial is testingActive Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan InstituteWho this might be right forInfluenza Vaccines Butantan Institute 533
Testing effectiveness (Phase 2)Study completedNCT00329966What this trial is testingSafety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or OlderWho this might be right forInfluenza Novartis 100
Testing effectiveness (Phase 2)Study completedNCT00296829What this trial is testingImmunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the ElderlyWho this might be right forOrthomyxoviridae InfectionInfluenzaMyxovirus Infection Sanofi Pasteur, a Sanofi Company 1,080
Large-scale testing (Phase 3)Study completedNCT05540522What this trial is testingEvaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or OlderWho this might be right forInfluenza, Human Pfizer 45,789
Testing effectiveness (Phase 2)Study completedNCT03669627What this trial is testingCT18 Infant Influenza Priming Study in Vaccine Naive InfantsWho this might be right forInfluenza Canadian Immunization Research Network 159
Post-approval studies (Phase 4)UnknownNCT06286488What this trial is testingEffectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated InfluenzaWho this might be right forInfluenzaObesityPregnancy; Infection+4 more Medical University of Warsaw 1,500
Large-scale testing (Phase 3)Study completedNCT02545543What this trial is testingEvaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of AgeWho this might be right forInfluenza, Human Seqirus 2,278
Post-approval studies (Phase 4)Study completedNCT06503900What this trial is testingSimultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy StudyWho this might be right forBirth OutcomesSafetyAdverse Event Following Immunization Duke University 98
Large-scale testing (Phase 3)Study completedNCT01201902What this trial is testingEvaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) VaccineWho this might be right forInfluenza Infection Green Cross Corporation 592
Post-approval studies (Phase 4)Not Yet RecruitingNCT07832201What this trial is testingA Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)Who this might be right forInfluenza Sinovac Biotech Co., Ltd 150